Litcius/Paper detail

Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice

María Celeste Morán, Ángel Ricardo Bence, María F. Sánchez Vallecillo, Claudia Lützelschwab, Marcelo Gastón Rodriguez, Romina Pardo, Fernando A. Goldbaum, Vanesa Zylberman, Santiago Daniel Palma, Belkys Maletto, Silvia M. Estein

2021Research in Veterinary Science11 citationsDOIOpen Access PDF

Topics & Concepts

CpG OligodeoxynucleotideAdjuvantImmunologyImmune systemAntibodyAntigenBALB/cNasal administrationMedicineChemistryBiochemistryGeneGene expressionDNA methylationBrucella: diagnosis, epidemiology, treatmentImmunotherapy and Immune ResponsesEscherichia coli research studies
Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice | Litcius